ALOOP THERAPEUTICS Trademark

Trademark Overview


On Monday, December 5, 2022, a trademark application was filed for ALOOP THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ALOOP THERAPEUTICS trademark a serial number of 97704430. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, March 15, 2024. This trademark is owned by Aloop Therapeutics ApS. The ALOOP THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Medicine for the treatment, prevention, or alleviation of rare and genetic diseases, cancer, precancerous diseases and benign tumors, diabetes, autoimmune diseases, inflammatory diseases, infectious diseases, neurodegenerative diseases, neuromuscular disorders, psychiatric disorders, movement disorders, extrapyramidal disorders, hyperkinetic movement disorders, hypokinetic movement disorders, parkinsonism, Parkinson's disease, sclerosis, gastrointestinal disorders and diseases, diarrhea, metabolic diseases, inborn Errors of Metabolism, lysosomal Storage Diseases, urea cycle disorders, cardiovascular diseases, neurodevelopmental disorders, cardiometabolic diseases

Research and development of vaccines and medicines
aloop therapeutics

General Information


Serial Number97704430
Word MarkALOOP THERAPEUTICS
Filing DateMonday, December 5, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, March 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedicine for the treatment, prevention, or alleviation of rare and genetic diseases, cancer, precancerous diseases and benign tumors, diabetes, autoimmune diseases, inflammatory diseases, infectious diseases, neurodegenerative diseases, neuromuscular disorders, psychiatric disorders, movement disorders, extrapyramidal disorders, hyperkinetic movement disorders, hypokinetic movement disorders, parkinsonism, Parkinson's disease, sclerosis, gastrointestinal disorders and diseases, diarrhea, metabolic diseases, inborn Errors of Metabolism, lysosomal Storage Diseases, urea cycle disorders, cardiovascular diseases, neurodevelopmental disorders, cardiometabolic diseases
Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesResearch and development of vaccines and medicines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 3, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 3, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAloop Therapeutics ApS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressKøbenhavn N DK-2200
DK

Trademark Events


Event DateEvent Description
Friday, March 15, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, March 15, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, November 30, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 30, 2023NON-FINAL ACTION E-MAILED
Thursday, November 30, 2023NON-FINAL ACTION WRITTEN
Friday, November 3, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 3, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 2, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 14, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 14, 2023NON-FINAL ACTION E-MAILED
Thursday, September 14, 2023NON-FINAL ACTION WRITTEN
Tuesday, September 12, 2023ASSIGNED TO EXAMINER
Tuesday, July 18, 2023PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Tuesday, July 18, 2023ASSIGNED TO LIE
Tuesday, March 14, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, January 3, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 8, 2022NEW APPLICATION ENTERED